+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Interventional Radiology Products Market - Global Forecast 2026-2032- Product Image
Interventional Radiology Products Market - Global Forecast 2026-2032- Product Image
New

Interventional Radiology Products Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5675042
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Interventional Radiology Products Market grew from USD 12.70 billion in 2025 to USD 13.53 billion in 2026. It is expected to continue growing at a CAGR of 6.61%, reaching USD 19.88 billion by 2032.

Introduction to the evolving interventional radiology products landscape driven by technological advances, clinical demand, and procurement imperatives

Interventional radiology sits at the intersection of technological innovation and clinical demand, reshaping how minimally invasive therapies are conceived, delivered, and reimbursed. Recent advances in imaging fidelity, device miniaturization, and procedural workflows have expanded clinician capabilities across a range of therapeutic domains. Consequently, device manufacturers and health systems alike face elevated expectations to deliver solutions that reduce procedure times, lower complication rates, and enable outpatient pathways while meeting rigorous regulatory and reimbursement standards.

Across the product landscape, developments touch both core consumables and high-value capital equipment. Clinicians increasingly expect devices that integrate with hybrid operating suites and advanced image guidance platforms, while procurement teams prioritize supply resilience and lifecycle total cost of ownership. As a result, strategic decisions now hinge on aligning engineering innovation with clinical evidence generation, regulatory strategy, and payer engagement to ensure sustained adoption and patient access.

How technological convergence, outpatient migration, and supply chain resilience are redefining commercial and clinical models in interventional radiology

The interventional radiology landscape is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. Image-guided precision and device interoperability have matured to the point where workflows are being redesigned around real-time data, allowing clinicians to perform more complex procedures with greater consistency. Concurrently, robotics and navigational systems are transitioning from niche applications to scalable tools that reduce operator variability and expand procedural access.

Parallel to technological change, clinical practice patterns are shifting toward outpatient and ambulatory settings as procedural techniques and perioperative protocols reduce the need for inpatient stays. This transition influences demand pathways for devices and consumables, accelerating the need for products optimized for ambulatory surgical centers and clinic-based interventions. Further, heightened focus on value-based care encourages device developers to substantiate clinical benefits with outcomes data, while supply-chain diversification and regional manufacturing investments respond to geopolitical and logistical pressures. Taken together, these shifts require stakeholders to adapt business models, prioritize cross-disciplinary partnerships, and reframe value propositions around outcomes, efficiency, and resilience.

Assessing the strategic ramifications of cumulative 2025 United States tariffs on manufacturing localization, sourcing strategies, and procurement dynamics

The cumulative effect of United States tariffs enacted or implemented in 2025 introduces material considerations across manufacturing, procurement, and pricing strategies for device makers and health systems. Tariff-related cost pressures can accentuate existing incentives to localize manufacturing footprints or to establish regional distribution hubs to mitigate duties and logistical disruptions. In response, some manufacturers will evaluate nearshoring of key production stages, selectively relocating precision machining, component assembly, or packaging closer to end markets to protect margins and lead times.

Moreover, tariff dynamics prompt reexamination of supplier contracts and sourcing strategies, encouraging longer-term agreements with diversified vendors and the qualification of alternative materials where clinically acceptable. Hospitals and ambulatory centers may experience incremental procurement complexity as purchasing teams balance cost, device compatibility, and regulatory conformity. Finally, the tariff environment reinforces the importance of transparent total cost analyses and collaborative supplier relationships that can preserve clinical continuity while enabling adaptive pricing and contracting approaches under shifting trade conditions.

Deep segmentation analysis revealing distinct adoption pathways across product classes, therapeutic applications, end-user settings, and route-to-market structures

Segmentation insights reveal differentiated demand drivers and commercialization pathways across device types, clinical applications, end users, and distribution models. On the product front, ablation devices-encompassing both microwave ablation devices and radiofrequency ablation devices-coexist alongside angioplasty balloons, catheters, embolic agents that include liquid embolics and particulate embolics, embolization coils, guidewires, vascular closure devices, and vascular stents with distinct carotid stents and peripheral vascular stents subtypes; each device class requires tailored clinical evidence and training programs to support adoption.

From an application perspective, neuro intervention procedures such as aneurysm embolization and stroke thrombectomy demand high-performance neuro-specific devices and integration with stroke networks, whereas oncology interventions including transarterial chemoembolization and tumor ablation-where tumor ablation methodologies span cryoablation, microwave ablation, and radiofrequency ablation-prioritize devices that enable precision, repeatability, and multimodality therapy. Pain management and vascular intervention segments impose different throughput, disposability, and cost constraints that influence product design.

End-user segmentation highlights that ambulatory surgical centers, clinics, and hospitals each present unique procurement cycles, capital budgets, and staffing models, requiring manufacturers to craft differentiated commercial approaches. Distribution channels bifurcate between direct sales and distributor sales, shaping service models, inventory strategies, and post-market support offerings. Taken together, these segmentation dimensions underscore the necessity of aligning clinical training, regulatory strategies, and commercial execution with the specific needs of each product, application, end user, and channel.

Regional dynamics shaping differentiated access, regulatory pathways, and commercial priorities across the Americas, EMEA, and Asia-Pacific healthcare markets

Regional dynamics vary substantially, creating distinct opportunities and operational challenges across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the confluence of advanced procedural volume, large tertiary care networks, and an active private sector creates fertile ground for high-complexity interventional devices and clinical trials, while payer systems and regulatory frameworks demand robust outcomes evidence and reimbursement alignment. Moving to Europe, Middle East & Africa, heterogeneity in procurement practices, regulatory alignment under centralized frameworks, and pockets of rapid private-sector growth necessitate adaptive market strategies that account for variable reimbursement and infrastructure maturity.

The Asia-Pacific region exhibits rapid adoption in urban centers driven by expanding hospital capacity, strong capital investment in healthcare infrastructure, and an increasing emphasis on locally relevant device solutions. However, diverse regulatory regimes and varying clinical practice patterns require tailored registration pathways and localized clinical support. Across regions, supply chain strategies, regulatory timelines, and clinician-training investments must be calibrated to regional patient pathways, hospital types, and technology readiness to ensure successful market entry and scale-up.

Company-level trends showing how R&D focus, partnerships, and service models are establishing competitive advantage in interventional radiology

Key corporate behaviors point to a blend of innovation through targeted R&D, strategic partnerships, and selective mergers and acquisitions to broaden product portfolios and clinical reach. Leading device manufacturers are investing in enhanced device-miniaturization, advanced materials, and integrated imaging-package solutions to improve procedural ergonomics and clinical outcomes. Strategic alliances with imaging companies, software vendors, and academic medical centers accelerate clinical validation and foster integrated offering development.

At the same time, smaller specialty players are carving niches by focusing on differentiated technologies such as novel embolic chemistries or next-generation stent platforms, often leveraging clinical evidence in specific procedural contexts. Across the competitive landscape, there is increasing emphasis on lifecycle service models, digital health adjuncts that facilitate remote monitoring and procedural analytics, and aftermarket support capabilities that improve retention with clinical customers. Overall, competitive advantage accrues to organizations that combine clinical evidence generation, supply reliability, and integrated service delivery.

Clear, implementable strategies for device makers and health systems to strengthen evidence, diversify supply chains, and evolve commercial models for durable advantage

Industry leaders should prioritize a set of actionable moves that enable resilient growth while responding to clinical and commercial exigencies. First, invest in clinical evidence generation that demonstrates comparative procedural benefits and real-world outcomes, thereby facilitating adoption across hospitals, ambulatory surgical centers, and clinics. Second, diversify manufacturing and supplier networks to reduce exposure to tariff and logistics volatility, while evaluating nearshoring or regional assembly to improve responsiveness to local demand.

Third, adapt commercial models to the end-user profile by deploying direct sales where clinical integration and training are critical and leveraging distributor channels where scale and local reach are paramount. Fourth, embed digital adjuncts and service-oriented offerings into product portfolios to create recurring revenue streams and strengthen clinical partnerships. Finally, pursue selective collaborations with imaging, software, and robotics partners to deliver integrated solutions that reduce procedural complexity and support value-based care discussions with payers. Taken together, these steps create a pragmatic roadmap for balancing innovation with operational resilience and commercial effectiveness.

Transparent, reproducible research methodology combining clinician interviews, secondary literature, and rigorous triangulation to validate interventional radiology insights

The research underpinning this report integrates primary qualitative inputs, secondary literature review, and methodological triangulation to ensure balanced, actionable insights. Primary inputs include structured interviews with interventional radiologists, hospital procurement leaders, and device industry executives, supplemented by clinical advisory group feedback to validate procedural trends and device utility. Secondary sources comprised peer-reviewed clinical literature, regulatory filings, company disclosures, and public health policy materials to contextualize technological and market dynamics.

Data synthesis employed triangulation, cross-validation of clinical claims, and scenario analysis to test the resilience of strategic conclusions under different operational contingencies. Attention to methodological rigor included documenting interview protocols, maintaining an audit trail of secondary sources, and enlisting clinical reviewers to verify technical characterizations. Throughout, the approach emphasized reproducibility and transparency to enable informed decision-making by commercial, clinical, and investor stakeholders.

Conclusion summarizing the interplay of innovation, evidence generation, and operational agility needed to succeed in interventional radiology device markets

In conclusion, the interventional radiology products landscape offers a dynamic intersection of clinical innovation and commercial complexity that rewards strategic focus on evidence, supply resilience, and integrated solutions. Technological advances in image guidance, ablation modalities, embolics, and stenting are widening procedural possibilities, while outpatient migration and payer priorities are reshaping value propositions. Concurrently, trade dynamics and regional heterogeneity underscore the importance of adaptable manufacturing and market-entry strategies.

Looking ahead, organizations that align product development with robust clinical evidence, invest in regional operational agility, and cultivate partnerships that deliver holistic procedural workflows will be best positioned to capture durable clinical and commercial value. Effective execution rests on marrying technical excellence with clear reimbursement strategies, post-market support, and clinician-focused training to translate innovation into sustained adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Interventional Radiology Products Market, by Product Type
8.1. Ablation Devices
8.1.1. Microwave Ablation Devices
8.1.2. Radiofrequency Ablation Devices
8.2. Angioplasty Balloons
8.3. Catheters
8.4. Embolic Agents
8.4.1. Liquid Embolics
8.4.2. Particulate Embolics
8.5. Embolization Coils
8.6. Guidewires
8.7. Vascular Closure Devices
8.8. Vascular Stents
8.8.1. Carotid Stents
8.8.2. Peripheral Vascular Stents
9. Interventional Radiology Products Market, by Application
9.1. Neuro Intervention
9.1.1. Aneurysm Embolization
9.1.2. Stroke Thrombectomy
9.2. Oncology Intervention
9.2.1. Transarterial Chemoembolization
9.2.2. Tumor Ablation
9.2.2.1. Cryoablation
9.2.2.2. Microwave Ablation Devices
9.2.2.3. Radiofrequency Ablation Devices
9.3. Pain Management
9.4. Vascular Intervention
10. Interventional Radiology Products Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Clinics
10.3. Hospitals
11. Interventional Radiology Products Market, by Distribution Channel
11.1. Direct Sales
11.2. Distributor Sales
12. Interventional Radiology Products Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Interventional Radiology Products Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Interventional Radiology Products Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Interventional Radiology Products Market
16. China Interventional Radiology Products Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. B. Braun SE
17.7. Becton, Dickinson and Company
17.8. BIOTRONIK SE & Co. KG
17.9. Boston Scientific Corporation
17.10. Cardinal Health, Inc.
17.11. Cook Medical LLC
17.12. GE HealthCare
17.13. Koninklijke Philips N.V.
17.14. Medtronic plc
17.15. Merit Medical Systems, Inc.
17.16. Siemens Healthineers AG
17.17. Stryker Corporation
17.18. Teleflex Incorporated
17.19. Terumo Corporation
List of Figures
FIGURE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY LIQUID EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PARTICULATE EMBOLICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIZATION COILS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GUIDEWIRES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR CLOSURE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CAROTID STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PERIPHERAL VASCULAR STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ANEURYSM EMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY STROKE THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TRANSARTERIAL CHEMOEMBOLIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CRYOABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY MICROWAVE ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 150. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 156. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. EUROPE INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 172. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 173. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 174. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 176. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 177. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 178. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. AFRICA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 195. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 196. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 197. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 199. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 200. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 201. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. ASEAN INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 206. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 207. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 208. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 210. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 211. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 212. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. GCC INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 228. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 229. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 230. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 231. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 232. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 233. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 234. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. BRICS INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 236. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 239. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 240. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 241. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 242. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 243. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 244. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 245. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. G7 INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 247. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 249. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 250. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 251. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 252. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 254. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 255. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 256. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. NATO INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. GLOBAL INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 260. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 271. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 272. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ABLATION DEVICES, 2018-2032 (USD MILLION)
TABLE 273. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY EMBOLIC AGENTS, 2018-2032 (USD MILLION)
TABLE 274. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY VASCULAR STENTS, 2018-2032 (USD MILLION)
TABLE 275. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY NEURO INTERVENTION, 2018-2032 (USD MILLION)
TABLE 277. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY ONCOLOGY INTERVENTION, 2018-2032 (USD MILLION)
TABLE 278. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY TUMOR ABLATION, 2018-2032 (USD MILLION)
TABLE 279. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. CHINA INTERVENTIONAL RADIOLOGY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Interventional Radiology Products market report include:
  • Abbott Laboratories
  • B. Braun SE
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • GE HealthCare
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Siemens Healthineers AG
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.53 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.88 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Interventional Radiology Market Report 2025 - Product Image

Interventional Radiology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Interventional Radiology Market Growth Analysis - Market Size, Share, Forecast Trends and Outlook Report (2025-2034) - Product Image

Interventional Radiology Market Growth Analysis - Market Size, Share, Forecast Trends and Outlook Report (2025-2034)

  • Report
  • 350 Pages
  • Global
From
Interventional Radiology Market Size, Share, Trends and Forecast by Product, Procedures, Application, End Use, and Region, 2025-2033 - Product Image

Interventional Radiology Market Size, Share, Trends and Forecast by Product, Procedures, Application, End Use, and Region, 2025-2033

  • Report
  • 146 Pages
  • Global
From
Interventional Radiology Systems - Global Strategic Business Report - Product Image

Interventional Radiology Systems - Global Strategic Business Report

  • Report
  • 500 Pages
  • Global
From
Radiology as a Service Market - Global Forecast 2026-2032 - Product Image

Radiology as a Service Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From

About the Interventional Radiology Market

Interventional Radiology (IR) is a medical specialty that uses imaging guidance to perform minimally invasive procedures. It is a subspecialty of radiology that uses imaging guidance such as X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to perform a variety of procedures. These procedures are used to diagnose and treat diseases in nearly every organ system. IR procedures are often used to treat conditions such as cancer, vascular diseases, and other conditions that require targeted treatments. IR is a rapidly growing field, with new technologies and techniques being developed to improve patient outcomes. IR procedures are often less invasive than traditional surgical procedures, resulting in shorter recovery times and fewer complications. IR is also used to perform image-guided biopsies, which can provide more accurate diagnosis and treatment. Some companies in the Interventional Radiology market include Siemens Healthineers, Philips Healthcare, GE Healthcare, Canon Medical Systems, and Toshiba Medical Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.